Syringe with PECVD lubrication

US11624115B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11624115-B2
Application numberUS-201916518480-A
CountryUS
Kind codeB2
Filing dateJul 22, 2019
Priority dateMay 12, 2010
Publication dateApr 11, 2023
Grant dateApr 11, 2023

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A syringe or other vessel having a substrate surface coated by PECVD is provided. The PECVD coating is made by generating plasma from a gaseous reactant comprising an organosilicon precursor and optionally O2. The lubricity, hydrophobicity and/or barrier properties of the coating are set by setting the ratio of the O2 to the organosilicon precursor in the gaseous reactant, and/or by setting the electric power used for generating the plasma. In particular, a lubricity coating made by said method is provided. Vessels coated by said method and the use of such vessels protecting a compound or composition contained or received in said coated vessel against mechanical and/or chemical effects of the surface of the uncoated vessel material are also provided.

First claim

Opening claim text (preview).

The invention claimed is: 1. A syringe comprising a barrel and a plunger, the barrel having an interior surface coated at least in part with a lubricity coating made by: (a) providing a gas comprising a monocyclic siloxane, O 2 , and a noble gas, in the vicinity of the interior surface; and (b) generating a plasma in the gas using charged electrodes, thus forming a coating on the interior surface by plasma enhanced chemical vapor deposition (PECVD) under conditions effective to form a lubricity coating on the interior surface comprising a crosslinked monocyclic siloxane chemical structure and having a plunger initiation force Fi of 4.8 to 11 N; wherein the conditions effective include: a ratio of the O 2 to the monocyclic siloxane, a power used for generating the plasma, a ratio of the noble gas to the monocyclic siloxane, or any combination thereof. 2. The syringe of claim 1 , in which the plunger initiation force F i is from 5.1 to 11 N. 3. The syringe of claim 1 , in which the plunger initiation force F i is from 5.4 to 11 N. 4. The syringe of claim 1 , in which a plunger maintenance force F m is from 3.5 to 11 N. 5. The syringe of claim 1 , in which a plunger maintenance force F m is from 4.3 to 11 N. 6. The syringe of claim 1 , in which a plunger maintenance force F m is from 4.4 to 11 N. 7. The syringe according to claim 1 which contains a medicament in contact with the lubricity coating. 8. The syringe of claim 1 , wherein the lubricity coating has an atomic ratio Si w O x C y or Si w N x C y wherein w is 1, x is from about 0.5 to about 2.4, and y is from about 0.6 to about 3. 9. The syringe of claim 1 , wherein the lubricity coating has an average thickness of from 10 to 1000 nm. 10. The syringe of claim 1 , wherein the syringe barrel is COC, wherein the gas in step (a) comprises octamethylcyclotetrasiloxane, O 2 and Ar, and wherein the plasma is generated by applying a power density from 6 W/ml to 0.1 W/ml in relation to the volume of the syringe lumen. 11. The syringe of claim 1 , which contains a medicament. 12. The syringe of claim 1 , in which the monocyclic siloxane comprises octamethylcyclotetrasiloxane (OMCTS).

Assignees

Inventors

Classifications

  • C23C16/30Primary

    Deposition of compounds, mixtures or solid solutions, e.g. borides, carbides, nitrides · CPC title

  • C23C16/50Primary

    using electric discharges {(generation and control of plasma in discharge tubes for surface treatment H01J37/32, H01J37/34)} · CPC title

  • Materials for reducing friction · CPC title

  • Coating cavities or hollow spaces, e.g. interior of tubes; Infiltration of porous substrates · CPC title

  • to obtain an anti-friction or anti-adhesive surface (rendering particulate materials free-flowing in general, e.g. making them hydrophobic B01J2/30) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11624115B2 cover?
A syringe or other vessel having a substrate surface coated by PECVD is provided. The PECVD coating is made by generating plasma from a gaseous reactant comprising an organosilicon precursor and optionally O2. The lubricity, hydrophobicity and/or barrier properties of the coating are set by setting the ratio of the O2 to the organosilicon precursor in the gaseous reactant, and/or by setting the…
Who is the assignee on this patent?
Sio2 Medical Products Inc
What technology area does this patent fall under?
Primary CPC classification C23C16/30. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Apr 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 4 related publications on this page (citations in our corpus or others sharing the same primary CPC).